Facebook
Twitter
Telegram
Report an ErrorOncoSec Medical Incorporated Balance Sheet 2011-2024 | ONCS
Annual Balance Sheet OncoSec Medical Incorporated
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-4.65 M | -39.9 M | -18.9 M | -25.1 M | -3.8 M | -11.4 M | -28.7 M | -32 M | -37.9 M | -4.97 M | -5.14 M | -2.46 M |
Long Term Debt |
937 K | 5.24 M | 481 K | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
1.11 M | 845 K | 500 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | 6.35 M | 636 K | 1.47 M | 1.14 M | 887 K | - | - | - | 979 K | 1.5 M |
Total Current Liabilities |
6.63 M | 7.96 M | 9.68 M | 4.98 M | 5.85 M | 3.4 M | 3.47 M | - | 1.32 M | 1.77 M | 2.02 M | - |
Total Liabilities |
15.8 M | 18.2 M | 16 M | 5.61 M | 7.32 M | 4.54 M | 4.35 M | 2.89 M | 1.32 M | 1.77 M | 3 M | 8.04 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-286 M | -252 M | -207 M | -164 M | -134 M | -94.9 M | -73.5 M | -46.6 M | -25.4 M | -13.4 M | -6.2 M | -3.84 M |
Total Assets |
21.9 M | 56.3 M | 29.9 M | 29.9 M | 30.2 M | 15.2 M | 32.4 M | 35.6 M | 39.4 M | 6.51 M | 7.43 M | 5.67 M |
Cash and Cash Equivalents |
6.7 M | 46 M | 20.4 M | 25.1 M | 3.8 M | 11.4 M | 28.7 M | 32 M | 37.9 M | 4.97 M | 5.14 M | 2.46 M |
Book Value |
6.12 M | 38.1 M | 13.9 M | 24.3 M | 22.9 M | 10.7 M | 28.1 M | 32.7 M | 38.1 M | 4.74 M | 4.43 M | -2.36 M |
Total Shareholders Equity |
6.12 M | 38.1 M | 13.9 M | 24.3 M | 22.9 M | 10.7 M | 28.1 M | 32.7 M | 38.1 M | 4.74 M | 4.43 M | -2.36 M |
All numbers in USD currency
Quarterly Balance Sheet OncoSec Medical Incorporated
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
4.7 M | 3.51 M | 4.13 M | 4.42 M | 1.12 M | 4.98 M | 1.23 M | 5.24 M | 6.13 M | 1.29 M | 1.45 M | 5.87 M | - | 558 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
15.3 M | 15.4 M | 15.8 M | 14.1 M | 21.9 M | 16.8 M | 18.2 M | 18.2 M | 16.6 M | 17.7 M | 16 M | 16 M | 7.56 M | 7.95 M | 5.61 M | 5.61 M | 4.09 M | 6.98 M | 7.32 M | 7.32 M | 4.61 M | 5.16 M | 4.54 M | 4.54 M | 4.34 M | 4.45 M | 4.35 M | 4.35 M | 1.51 M | 3.18 M | 2.89 M | 2.89 M | 896 K | 1.32 M | 1.32 M | 1.18 M | 2.69 M | 1.85 M | 1.77 M | 1.77 M | 5.02 M | 2.83 M | 3 M | 3 M | - | 3.56 M | 8.04 M | 8.04 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-271 M | -294 M | -286 M | -278 M | -231 M | -262 M | -252 M | -252 M | -188 M | -220 M | -207 M | -207 M | -150 M | -174 M | -164 M | -164 M | -112 M | -142 M | -134 M | -134 M | -84.5 M | -101 M | -94.9 M | -94.9 M | -60.7 M | -79.1 M | -73.5 M | -73.5 M | -34 M | -53.6 M | -46.6 M | -46.6 M | -18 M | -29.4 M | -25.4 M | -25.4 M | -9.85 M | -15.4 M | -13.4 M | -13.4 M | -3.8 M | -8.23 M | -6.2 M | -6.2 M | - | -1.12 M | -3.84 M | -3.84 M |
Total Assets |
35.1 M | 14.4 M | 21.9 M | 28 M | 70 M | 45.6 M | 56.3 M | 56.3 M | 19.8 M | 33.9 M | 29.9 M | 29.9 M | 32.2 M | 23.2 M | 29.9 M | 29.9 M | 22.1 M | 32.2 M | 30.2 M | 30.2 M | 24.3 M | 18.7 M | 15.2 M | 15.2 M | 32.9 M | 28.1 M | 32.4 M | 32.4 M | 32.7 M | 30.4 M | 35.6 M | 35.6 M | 19.8 M | 35.7 M | 39.4 M | 39.4 M | 10.7 M | 17.1 M | 6.51 M | 6.51 M | 2.98 M | 5.52 M | 7.43 M | 7.43 M | - | 4.14 M | 5.67 M | 5.67 M |
Cash and Cash Equivalents |
25.2 M | - | 17.3 M | 22.1 M | 60.3 M | 35.7 M | 46 M | 46 M | 9.26 M | 24 M | 20.4 M | 20.4 M | 24.5 M | 16.9 M | 25.1 M | 25.1 M | 17.9 M | 19 M | 3.8 M | 3.8 M | 20.5 M | 14.7 M | 11.4 M | 21.4 M | 28.8 M | 24.4 M | 28.7 M | 24.4 M | 30.7 M | 26.9 M | 32 M | 26.9 M | 18.5 M | 34 M | 37.9 M | 34 M | 8.98 M | 15.2 M | 4.97 M | 15.2 M | 456 K | 3.53 M | 5.14 M | 3.53 M | 3.69 K | 1.41 M | 2.46 M | 1.41 M |
Book Value |
19.8 M | -984 K | 6.12 M | 13.9 M | 48.1 M | 28.8 M | 38.1 M | 38.1 M | 3.17 M | 16.2 M | 13.9 M | 13.9 M | 24.7 M | 15.3 M | 24.3 M | 24.3 M | 18 M | 25.2 M | 22.9 M | 22.9 M | 19.7 M | 13.5 M | 10.7 M | 10.7 M | 28.6 M | 23.6 M | 28.1 M | 28.1 M | 31.2 M | 27.2 M | 32.7 M | 32.7 M | 18.9 M | 34.4 M | 38.1 M | 38.2 M | 8.02 M | 15.2 M | 4.74 M | 4.74 M | -2.04 M | 2.69 M | 4.43 M | 4.43 M | - | 581 K | -2.36 M | -2.36 M |
Total Shareholders Equity |
19.8 M | -984 K | 6.12 M | 13.9 M | 48.1 M | 28.8 M | 38.1 M | 28.8 M | 3.17 M | 16.2 M | 16.2 M | 16.2 M | 24.7 M | 15.3 M | 15.3 M | 15.3 M | 18 M | 25.2 M | 22.9 M | 25.2 M | 19.7 M | 13.5 M | 10.7 M | 10.7 M | 28.6 M | 23.6 M | 28.1 M | 28.1 M | 31.2 M | 27.2 M | 32.7 M | 32.7 M | 18.9 M | 34.6 M | 38.1 M | 34.6 M | 8.02 M | 15.2 M | 4.74 M | 15.2 M | -2.04 M | 2.69 M | 4.43 M | 4.43 M | - | 581 K | -2.36 M | -2.36 M |
All numbers in USD currency